Table 4.
Frequency and prevalence of sleep medication use in girls and women with a sleep problem by medication type and questionnaire year
| Year of questionnaire [n (%)] | |||||||
|---|---|---|---|---|---|---|---|
| Medication | 2000 (n=147) | 2002 (n=166) | 2004 (n=172) | 2006 (n=178) | 2009 (n=188) | 2011 (n=172) | Total |
| Melatonin | 1 (0.7) | 2 (1.2) | 3 (1.7) | 6 (3.4) | 10 (5.3) | 9 (5.2) | 31 (3.0) |
| Antiepileptic drug | 11 (7.5) | 5 (3.0) | 1 (0.6) | 2 (1.1) | 1 (0.5) | 2 (1.2) | 22 (2.2) |
| Benzodiazepine^ | 3 (2.0) | 3 (1.8) | 3 (1.7) | 4 (2.3) | 2 (1.1) | 4 (2.3) | 19 (1.9) |
| Benzodiazepine# | 3 (2.0) | 3 (1.8) | 1 (0.6) | 4 (2.3) | 3 (1.6) | 4 (2.3) | 18 (1.8) |
| Clonidine | 0 | 2 (1.2) | 2 (1.2) | 5 (2.8) | 4 (2.1) | 4 (2.3) | 17 (1.7) |
| Trimeprazine | 1 (0.7) | 0 | 4 (2.3) | 5 (2.8) | 3 (1.6) | 3 (1.7) | 16 (1.6) |
| Amitriptyline | 1 (0.7) | 2 (1.2) | 2 (1.2) | 2 (1.1) | 3 (1.6) | 2 (1.2) | 12 (1.2) |
| Risperidone | 1 (0.7) | 4 (2.4) | 1 (0.6) | 3 (1.7) | 1 (0.5) | 0 | 10 (1.0) |
| Promethazine | 2 (1.4) | 0 | 3 (1.7) | 1 (0.6) | 0 | 1 (0.6) | 7 (0.7) |
| Miscellaneous | 2 (1.4) | 0 | 1 (0.6) | 0 | 1 (0.5) | 2 (1.2) | 6 (0.6) |
| Olanzapine | 0 | 1 (0.6) | 0 | 1 (0.6) | 1 (0.5) | 2 (1.2) | 5 (0.5) |
| Chloral hydrate | 0 | 1 (0.6) | 1 (0.6) | 2 (1.1) | 0 | 1 (0.6) | 5 (0.5) |
| Haloperidol | 0 | 1 (0.6) | 0 | 0 | 1 (0.5) | 1 (0.6) | 3 (0.3) |
| Hypnotics | 2 (1.4) | 0 | 0 | 0 | 1 (0.5) | 0 | 3 (0.3) |
| Mirtazapine | 0 | 0 | 1 (0.6) | 0 | 0 | 0 | 1 (0.6) |
| Fluoxetine | 0 | 1 (0.6) | 0 | 0 | 0 | 0 | 1 (0.6) |
Clobazam, clonazepam and diazepam
Nitrazepam, lorazepam, temazepam and oxazepam